Updated time: 2024-03-05 14:23:11
07A-1100702
2021-10-18
TW I832469
Epidemics like COVID-19 are emerging as a major concern to public health. Lateral flow immunoassay (LFIA) is a commonly used tool for point-of-care testing (POCT) of the diseases. Although LFIA is fast and low-cost, it provides only qualitative information. This invention discloses a method for rapid, quantitative, and sensitive immunodiagnostics using gold nanoparticles and colored latex beads as the reporters. The method, named as spatial modulation assisted lateral flow immunoassay (SMALFIA), utilizes a phase lock-in technique to reduce background levels and therefore enhance the detection sensitivity. The instrument has the advantages of low maintenance, high safety, low cost, high portability, and full compatibility with existing POCT technologies. No relevant competing technologies and products are available in the market.
- New invention, the first in the world
- Fully compatible with existing POCT technologies; Suitable for use with various LFIA strips
- Low cost, Low maintenance, High safety, High portability
- A prototype of the platform has been completed and ready for technology transfer
- High sensitivity detection of COVID-19 and other infectious diseases using commercially available LFIA strips
- Rapid diagnosis of infectious and chronical diseases using commercially available LFIA strips
- Quantitative diagnosis of infectious and chronical diseases as well as physiological examination at home using commercially available LFIA strips for long-term tracking

Fig1. SMALFIA of luteinizing hormone (LH) in the urine using gold nanoparticles as the reporters.

Fig2. SMALFIA of the nucleoprotein of SARS-CoV-2 using colored latex beads as the reporters. The limit of detection (LOD) is ~40 pg/mL, about 5-fold better than that of the detection with the naked eye. A set of strips used in this experiment is shown to the right.
Huan-Cheng Chang、Hui Yuen Yung、Yi-Xiu Tang
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Spatial Modulation Assisted Lateral Flow Immunoassay (SMALFIA)